These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26600055)

  • 1. Single Nucleotide Polymorphism of Interleukin-18 and Interleukin-18 Receptor and the Risk of Papillary Thyroid Cancer.
    Chung JH; Lee YC; Eun YG; Chung JH; Kim SK; Chon S; Oh SJ; Rhee SY; Hong IK
    Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):598-603. PubMed ID: 26600055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.
    Ban JY; Kim MK; Park SW; Kwon KH
    Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
    Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
    Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
    Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
    Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
    Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
    Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
    Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
    J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
    Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
    Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
    Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
    J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
    Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
    Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 22 polymorphisms and papillary thyroid cancer.
    Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
    J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
    Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
    Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.